Effects of an Online Yoga Program on Exercise Capacity and Quality of Life in Bronchiectasis Patients
YOGA-BR
Effects of an Eight-Week Online Yoga Program on Pulmonary Function, Exercise Capacity, Dyspnea, and Quality of Life in Patients With Non-Cystic Fibrosis Bronchiectasis: A Randomized Controlled Trial
1 other identifier
interventional
70
1 country
1
Brief Summary
Bronchiectasis is a chronic lung disease characterized by persistent cough, sputum production, shortness of breath, and recurrent infections, which can reduce physical capacity and quality of life. Non-pharmacological interventions, such as exercise-based approaches, are increasingly used to support symptom management in these patients. This study aimed to evaluate the effects of an eight-week online yoga program on exercise capacity, dyspnea severity, respiratory function, and quality of life in adults with non-cystic fibrosis bronchiectasis. A total of 70 participants were randomly assigned to either a yoga intervention group or a control group. The yoga group participated in supervised online sessions three times per week, including breathing exercises, postures, and relaxation techniques, while the control group received usual care without additional intervention. Outcomes were assessed at baseline and after eight weeks using pulmonary function tests, the six-minute walk test (6MWT), the Modified Medical Research Council (mMRC) Dyspnea Scale, and the St. George's Respiratory Questionnaire (SGRQ). The study investigated whether yoga could provide a safe and effective complementary approach to improve symptoms and functional capacity in individuals with bronchiectasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedFirst Submitted
Initial submission to the registry
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedApril 21, 2026
April 1, 2026
5 months
April 8, 2026
April 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6-Minute Walk Distance (6MWT)
The change in functional exercise capacity assessed by the six-minute walk test (6MWT), measured as the distance (in meters) walked in six minutes.
Baseline and 8 weeks
Secondary Outcomes (7)
Dyspnea Severity (mMRC Scale)
Baseline and 8 weeks
Health-Related Quality of Life (SGRQ)
Baseline and 8 weeks
FEV1
Baseline and 8 weeks
FVC
Baseline and 8 weeks
FEV1/FVC
Baseline and 8 weeks
- +2 more secondary outcomes
Study Arms (2)
Yoga Group
EXPERIMENTALParticipants in this group received an eight-week supervised online yoga program consisting of breathing exercises, postures (asanas), and relaxation techniques, performed three times per week (24 sessions in total).
Control Group
NO INTERVENTIONParticipants in this group received usual care without any additional intervention during the study period
Interventions
The intervention consisted of an eight-week online supervised yoga program including breathing exercises (pranayama), physical postures (asanas), and relaxation techniques. Sessions were conducted three times per week, totaling 24 sessions. The program was designed to improve respiratory control, chest expansion, and overall physical awareness.
Eligibility Criteria
You may qualify if:
- Adults aged 30-55 years
- Diagnosed with non-cystic fibrosis bronchiectasis based on clinical and radiological findings
- Clinically stable condition
- No participation in a structured exercise program within the previous 3 months
- Voluntary agreement to participate
You may not qualify if:
- Presence of additional respiratory diseases
- Acute exacerbation or antibiotic use within the previous 4 weeks
- Physical or cognitive impairments limiting participation
- Age above 55 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Medipol University, Faculty of Physiotherapy and Rehabilitation
Istanbul, Beykoz, 34810, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention (yoga program), neither participants nor investigators were blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 8, 2026
First Posted
April 21, 2026
Study Start
January 15, 2025
Primary Completion
June 20, 2025
Study Completion
October 15, 2025
Last Updated
April 21, 2026
Record last verified: 2026-04